Second and Third Generation Antipsychotics

A Comprehensive Handbook

Nonfiction, Health & Well Being, Medical, Specialties, Physical Medicine & Rehabilitation
Cover of the book Second and Third Generation Antipsychotics by Thomas L. Schwartz, AuthorHouse
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Thomas L. Schwartz ISBN: 9781524619732
Publisher: AuthorHouse Publication: August 10, 2016
Imprint: AuthorHouse Language: English
Author: Thomas L. Schwartz
ISBN: 9781524619732
Publisher: AuthorHouse
Publication: August 10, 2016
Imprint: AuthorHouse
Language: English

The second generation antipsychotics are a complex class of psychiatric medications, applicable to a diverse range of both FDA approved treatment indications and off-label uses. This variety stems largely from the unique pharmacodynamic profile of each agent, and often necessitates the employment of unique dosing strategies across the treatment of the varied psychiatry disorders, including schizophrenia, bipolar mania and depression, major depressive disorder, and autism. Despite the shared mechanism of dopamine D2 and serotonin-2a dual receptor blockade, which mediates the antipsychotic and antimanic properties of the second generation antipsychotics, the unique pharmacodynamic signature of each agent is subsequently responsible for the additional and varied antidepressant, anxiolytic, hypnotic, and tolerability profile observed with each drug. Using an evidence based approach, this comprehensive handbook aims to highlight and discuss data relevant to treatment indications, off-labels uses, and dosing strategies of the 11 currently FDA approved second generation antipsychotics, with a strong emphasis on the pharmacodynamic profiles of these drugs. With the advent of three relatively new antipsychotics (lurasidone in 2011, brexpiprazole in 2015, and cariprazine in 2015), this text will serve as an excellent reference for practicing physicians, research investigators, and medical students alike. This review addresses not only these clinical applications, but provides physicians with the tools necessary to optimize treatment based upon patient diagnosis, proper antipsychotic selection, and implementation of an appropriate dosing strategy, thereby striking an essential balance between treatment efficacy and patient tolerability.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The second generation antipsychotics are a complex class of psychiatric medications, applicable to a diverse range of both FDA approved treatment indications and off-label uses. This variety stems largely from the unique pharmacodynamic profile of each agent, and often necessitates the employment of unique dosing strategies across the treatment of the varied psychiatry disorders, including schizophrenia, bipolar mania and depression, major depressive disorder, and autism. Despite the shared mechanism of dopamine D2 and serotonin-2a dual receptor blockade, which mediates the antipsychotic and antimanic properties of the second generation antipsychotics, the unique pharmacodynamic signature of each agent is subsequently responsible for the additional and varied antidepressant, anxiolytic, hypnotic, and tolerability profile observed with each drug. Using an evidence based approach, this comprehensive handbook aims to highlight and discuss data relevant to treatment indications, off-labels uses, and dosing strategies of the 11 currently FDA approved second generation antipsychotics, with a strong emphasis on the pharmacodynamic profiles of these drugs. With the advent of three relatively new antipsychotics (lurasidone in 2011, brexpiprazole in 2015, and cariprazine in 2015), this text will serve as an excellent reference for practicing physicians, research investigators, and medical students alike. This review addresses not only these clinical applications, but provides physicians with the tools necessary to optimize treatment based upon patient diagnosis, proper antipsychotic selection, and implementation of an appropriate dosing strategy, thereby striking an essential balance between treatment efficacy and patient tolerability.

More books from AuthorHouse

Cover of the book Wanted One Surrogate Mother by Thomas L. Schwartz
Cover of the book Lost in Rio by Thomas L. Schwartz
Cover of the book Paintings in Under a Thousand Words by Thomas L. Schwartz
Cover of the book Prized Possession by Thomas L. Schwartz
Cover of the book Protector of the Line by Thomas L. Schwartz
Cover of the book The Coma by Thomas L. Schwartz
Cover of the book Back Home to Montana by Thomas L. Schwartz
Cover of the book Secret Green Beret Commandos in Cambodia by Thomas L. Schwartz
Cover of the book The Look of Things by Thomas L. Schwartz
Cover of the book Charlie, the Christmas Camel by Thomas L. Schwartz
Cover of the book An Ordinary Man - a Great God by Thomas L. Schwartz
Cover of the book Survival in the Wild by Thomas L. Schwartz
Cover of the book In the Lions Mouth and Other Stories by Thomas L. Schwartz
Cover of the book Ice Dance by Thomas L. Schwartz
Cover of the book Fire at the Altar by Thomas L. Schwartz
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy